BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38170968)

  • 1. Mitochondrial-Targeting Nanotrapper Captured Copper Ions to Alleviate Tumor Hypoxia for Amplified Photoimmunotherapy in Breast Cancer.
    Huang W; Yu M; Sun S; Yu L; Wen S; Liu Y; Peng Z; Hao H; Wang T; Wu M
    ACS Appl Mater Interfaces; 2024 Jan; 16(2):2166-2179. PubMed ID: 38170968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable NIR-II Pseudo Conjugate Polymeric Nanoparticles Amplify Photodynamic Immunotherapy via Alleviation of Tumor Hypoxia and Tumor-Associated Macrophage Reprogramming.
    Wan J; Zhang X; Tang D; Liu T; Xiao H
    Adv Mater; 2023 Aug; 35(31):e2209799. PubMed ID: 37276889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancer.
    Yang G; Xu L; Xu J; Zhang R; Song G; Chao Y; Feng L; Han F; Dong Z; Li B; Liu Z
    Nano Lett; 2018 Apr; 18(4):2475-2484. PubMed ID: 29565139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic reprogramming mediated PD-L1 depression and hypoxia reversion to reactivate tumor therapy.
    Zhou Z; Liu Y; Song W; Jiang X; Deng Z; Xiong W; Shen J
    J Control Release; 2022 Dec; 352():793-812. PubMed ID: 36343761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria Targeted O
    Yuan P; Deng FA; Liu YB; Zheng RR; Rao XN; Qiu XZ; Zhang DW; Yu XY; Cheng H; Li SY
    Adv Healthc Mater; 2021 Jun; 10(12):e2100198. PubMed ID: 33938637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor homing-penetrating and nanoenzyme-augmented 2D phototheranostics against hypoxic solid tumors.
    Wu C; Zhang Y; Wei X; Li N; Huang H; Xie Z; Zhang H; Yang G; Li M; Li T; Yang H; Li S; Qin X; Liu Y
    Acta Biomater; 2022 Sep; 150():391-401. PubMed ID: 35917909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategic Design of Conquering Hypoxia in Tumor for Advanced Photodynamic Therapy.
    Zhang C; Hu X; Jin L; Lin L; Lin H; Yang Z; Huang W
    Adv Healthc Mater; 2023 Sep; 12(24):e2300530. PubMed ID: 37186515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hybrid metal-organic framework nanomedicine-mediated photodynamic therapy and hypoxia-activated cancer chemotherapy.
    Jia Z; Gao Y; Ni J; Wu X; Mao Z; Sheng G; Zhu Y
    J Colloid Interface Sci; 2023 Jan; 629(Pt B):379-390. PubMed ID: 36162395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors.
    Wu Y; Ding L; Zheng C; Li H; Wu M; Sun Y; Liu X; Zhang X; Zeng Y
    Acta Biomater; 2022 Nov; 153():419-430. PubMed ID: 36115655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria-targeted nanoplatforms for enhanced photodynamic therapy against hypoxia tumor.
    Wen J; Luo Y; Gao H; Zhang L; Wang X; Huang J; Shang T; Zhou D; Wang D; Wang Z; Li P; Wang Z
    J Nanobiotechnology; 2021 Dec; 19(1):440. PubMed ID: 34930284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grade-targeted nanoparticles for improved hypoxic tumor microenvironment and enhanced photodynamic cancer therapy.
    Tao YK; Hou XY; Gao H; Zhang X; Zuo FM; Wang Y; Li XX; Jiang G
    Nanomedicine (Lond); 2021 Feb; 16(3):221-235. PubMed ID: 33533660
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor microenvironment-responsive nanohybrid for hypoxia amelioration with photodynamic and near-infrared II photothermal combination therapy.
    Zhang P; Wu Q; Yang J; Hou M; Zheng B; Xu J; Chai Y; Xiong L; Zhang C
    Acta Biomater; 2022 Jul; 146():450-464. PubMed ID: 35526739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Ca
    Zhu J; Jiao A; Li Q; Lv X; Wang X; Song X; Li B; Zhang Y; Dong X
    Acta Biomater; 2022 Jan; 137():252-261. PubMed ID: 34653696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-generating oxygen enhanced mitochondrion-targeted photodynamic therapy for tumor treatment with hypoxia scavenging.
    Yang Z; Wang J; Ai S; Sun J; Mai X; Guan W
    Theranostics; 2019; 9(23):6809-6823. PubMed ID: 31660070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria-Targeting Upconversion Nanoparticles@MOF for Multiple-Enhanced Photodynamic Therapy in Hypoxic Tumor.
    Chen Y; Yang Y; Du S; Ren J; Jiang H; Zhang L; Zhu J
    ACS Appl Mater Interfaces; 2023 Aug; 15(30):35884-35894. PubMed ID: 37487181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-action nanoplatform with a synergetic strategy to promote oxygen accumulation for enhanced photodynamic therapy against hypoxic tumors.
    Ren C; Xu X; Yan D; Gu M; Zhang J; Zhang H; Han C; Kong L
    Acta Biomater; 2022 Jul; 146():465-477. PubMed ID: 35526738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy.
    Guo X; Qu J; Zhu C; Li W; Luo L; Yang J; Yin X; Li Q; Du Y; Chen D; Qiu Y; Lou Y; You J
    Drug Deliv; 2018 Nov; 25(1):585-599. PubMed ID: 29461122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Oxygen Self-sufficient Fluorinated Nanoplatform for Relieved Tumor Hypoxia and Enhanced Photodynamic Therapy of Cancers.
    Ma S; Zhou J; Zhang Y; Yang B; He Y; Tian C; Xu X; Gu Z
    ACS Appl Mater Interfaces; 2019 Feb; 11(8):7731-7742. PubMed ID: 30694643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-like copper-encapsulating magnetic nanoassemblies for switchable T1-weighted MRI and potentiating chemo-/photo-dynamic therapy.
    Li T; Rao B; Xu D; Zhou J; Sun W; Zhi X; Zhang C; Cui D; Xu H
    Acta Biomater; 2022 Nov; 153():431-441. PubMed ID: 36174937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Hypoxia Nanoplatforms for Enhanced Photosensitizer Uptake and Photodynamic Therapy Effects in Cancer Cells.
    Nkune NW; Abrahamse H
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.